More

    Dr. Girish Sahni, Former Director of CSIR-IMTECH, Passes Away at 68

    Dr. Girish Sahni, a pioneering scientist and former director of CSIR-IMTECH, passed away at 68. He was known for his groundbreaking work in biotechnology.

    - Advertisement -

    On Sunday, Dr. Girish Sahni, the former director of the Council of Scientific and Industrial Research-Institute of Microbial Technology (CSIR-IMTECH), passed away. He was sixty-eight.

    Renowned Scientist Dr. Girish Sahni Dies at 68

    Sahni, who was born on March 2, 1956, attended Punjab University (PU) to complete his undergraduate and graduate studies in microbiology (1973–1978). He then continued on to the Indian Institute of Science (IISc), Bangalore, to pursue a PhD. During his post-PhD career, he held prominent positions at the Albert Einstein College of Medicine in New York, Rockefeller University in New York, and the University of California, Santa Barbara.

    Subsequently, Sahni took on the positions of secretary of the Department of Scientific and Industrial Research, Ministry of Science and Technology, and director general of CSIR. In addition to these roles, he held visiting professorships at the Indian School of Business, a Bhatnagar fellow at IMTECH and the Institute of Himalayan Bioresource Technology (IHBT), and an honorary professorship at PU.

    Dr. Sahni’s Journey: From University to Acclaim

    Dr. Sahni was an expert in biotechnology, molecular biology, and protein engineering. He made important advances in the field of protein-based cardiovascular medications, especially in the creation of “clot busters” and the understanding of how they function in the human body.

    Under his direction, his group created the technique for natural streptokinase, the first clot-buster medication made in India. This technology was valued at more than $160 million. Additionally, they were in charge of the world’s first fourth-generation “anti-thrombotic” clot busters, which were developed in a revolutionary manner.

    Conclusion

    With the death of Dr. Girish Sahni, a chapter in Indian scientific research has closed. His contributions to biotechnology have had a lasting impact on the scientific community worldwide, especially in the area of cardiovascular care. His groundbreaking study, which served as the impetus for India’s first clot-buster medication, has save countless deaths. Future generations of Indian scientists and researchers will be motivated by Dr. Sahni’s legacy.

    Read: Nalin Prabhat to Take Helm as Jammu and Kashmir Police Chief

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Latest Posts

    India Expresses Willingness to Facilitate Peace Talks

    India stated on Friday that it is prepared to help positively to the restoration of peace between Russia and Ukraine, but that the two...

    Frances Tiafoe Defeats Ben Shelton in Epic Five-Set Battle at US Open

    It turned out to be a Friday matinee hit, even though it deserved to be on primetime. In front of a crowded Arthur Ashe...

    Principal Dr. Sandip Ghosh Suspended by IMA Amid Controversy

    New Delhi: Dr. Sandip Ghosh the former principal of Kolkata's RG Kar Hospital, where a doctor was sexually assaulted and killed this month, has...

    Death Penalty for ‘Deadpool Killer’ Wade Wilson After Gruesome Murders

    The Deadpool Killer, Wade Wilson, was given a death sentence on Tuesday, August 27, for his heinous murder of two people in Florida "for...